AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹196 Cr | ₹174 Cr | ₹170 Cr | ₹197 Cr | ₹164 Cr |
What is the latest Revenue of AMBALAL SARABHAI ENTERPRISES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹196 Cr |
| Mar2024 | ₹174 Cr |
| Mar2023 | ₹170 Cr |
| Mar2022 | ₹197 Cr |
| Mar2021 | ₹164 Cr |
How is Revenue of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹196 Cr | 13.03 | |
| Mar2024 | ₹174 Cr | 1.93 | |
| Mar2023 | ₹170 Cr | -13.45 | |
| Mar2022 | ₹197 Cr | 20.23 | |
| Mar2021 | ₹164 Cr | - | |
Compare Revenue of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹247.7 Cr | -2.2% | NA | -9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -2.2% |
NA |
-9.9% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses